Deciphera Pharmaceuticals

Deciphera Pharmaceuticals

Deciphera Pharmaceuticals

Deciphera was established in 2003 based on a deep scientific understanding of kinase inhibitors and a team dedicated to developing sophisticated approaches to therapeutic targeting of kinases.
Founded
2003
Raised
$195M
Follow us
Alexa global traffic share
$128,000,000 IPO
Xconomy

Deciphera IPO Drums Up $128M for Cancer Drug Studies

Health Stock markets Earnings
PE HUB

VC-backed Deciphera Pharmaceuticals debuts IPO

Health Stock markets
$52,000,000 Venture capital (Series C)
businesswire

Deciphera Pharmaceuticals Announces $52 Million Series C Financing to Advance Novel Clinical-Stage Oncology Pipeline

$15,000,000 Venture capital (Series B)
FinSMEs

Deciphera Pharmaceuticals Increases Size of Series B Round to over $90M

Health Funding